Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03881657 Completed - Obesity Clinical Trials

Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border

Start date: November 24, 2015
Phase: N/A
Study type: Interventional

This study evaluated whether patients with severe and persistent mental illness (SPMI) who received coordinated co-located behavioral health and primary care services were more likely to improve health outcomes after 12 months compared to SPMI patients who receive only behavioral health services from the local mental health authority (LMHA) Tropical Texas Behavioral Health (TTBH).The study employed a randomized control trial (RCT) design where intervention participants receiving integrated behavioral health were compared to control participants receiving the usual care provided within an LMHA for SPMI patients. Patients were placed in each group using a randomized number process. Demographic and health outcome data were collected from intervention and control participants at baseline. Health outcome data was subsequently collected at 6-month and 12-month follow-up points.

NCT ID: NCT03847350 Completed - Clinical trials for Essential Hypertension

Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension

Start date: July 1, 2015
Study type: Observational

The purpose of this study is: To evaluate the effects of NEBILET®(Nebivolol), used as monotherapy or in combination with other antihypertensive agents, in the control of BP and in the metabolic profile of patients with essential hypertension (with or without co-morbidities) after 12 weeks and 24 weeks.

NCT ID: NCT03839979 Completed - Hypertension Clinical Trials

HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt

Start date: October 1, 2018
Study type: Observational

An observational double-blind cohort study that examined the association between HCV viral hepatitis, blood sugar level and systolic blood pressure in the Egyptian population

NCT ID: NCT03828955 Completed - Hypertension Clinical Trials

Evaluation of Soybean Peptides Product on Regulation of Blood Pressure Effect by Clinical Trial

Start date: March 2016
Phase: N/A
Study type: Interventional

This is the report to assess the effect of supplementation with soybean peptides on blood pressure among people with mild hypertension. Overall, soybean peptides consumption for 8 weeks could successfully reduce mean diastolic and systolic BP through the suppression of ACE that is linked to downstream suppresion of angiotensin II formation, which further decreases the sympathetic outflow that leads to hypertension.

NCT ID: NCT03803306 Completed - Clinical trials for Essential Hypertension

Vedic Medical Astrology in Essential Hypertension

Start date: July 12, 2018
Phase: N/A
Study type: Interventional

Previous studies have explored the correlation and impact of astrological events in relation of diseases, health concerns and relationship between birth chart and disease risk. Cardiovascular conditions, sleep and fertility were found significantly associated with moon phase. However, to best of our knowledge no study has documented the impact of astrological intervention in disease management. This is a randomised, multi-center, double blind placebo controlled clinical trial with two parallel arms. This trial aims to evaluate the effectiveness of Vedic medical astrological intervention for patients with mild to moderate hypertension,with respect to decreasing their blood pressure and improving their quality of life.

NCT ID: NCT03780309 Completed - Hypertension Clinical Trials

Postexercise Hypotension and Exercise Adherence

Start date: October 28, 2016
Phase: N/A
Study type: Interventional

Sedentary (n=24) adults ≥18 yr with elevated BP to established hypertension were enrolled into this randomized clinical trial entitled, 'Blood Pressure UtiLizing Self-Monitoring after Exercise study or PULSE'. Participants were randomly assigned to either an exercise only (EXERCISE; n=12) or exercise plus BP self-monitoring (EXERCISE+PEH) (n=12) group. All participants participated in a 12 wk supervised moderate intensity aerobic exercise training program 40 min/d for 3 d/wk. In addition, they were encouraged to exercise at home ≥30 min/d for 1-2 d/wk. All participants self-monitored exercise with a traditional calendar recording method and heart rate (HR) monitor. In addition to traditional exercise self-monitoring (EXERCISE), individuals in the EXERCISE+PEH group were given a home BP monitor to assess home BP twice daily (in the morning upon awakening and in the evening) and prior to and after voluntary home exercise sessions. Resting BP, peak oxygen consumption (VO2peak), physical activity, dietary and salt intake, and antihypertensive medication adherence were measured before and after the 12 wk supervised exercise training program. In addition, integrated social-cognitive predictors of exercise that included questionnaires on exercise self-efficacy, barriers self-efficacy, outcome expectations for exercise, exercise intention, and affective responses to exercise were measured before and after the 12 wk supervised exercise training program. Four weeks following the completion of exercise training, self-reported exercise levels were assessed during a telephone interview in both groups. Among EXERCISE+PEH only, self-monitoring of BP was also self-reported during this telephone interview.

NCT ID: NCT03762304 Completed - Hypertension Clinical Trials

The Effect of Household-based Screening on Blood Pressure Changes in South Africa

Start date: February 2008
Study type: Observational

This study will evaluate the effect of household-based screening and care encouragement for blood pressure on subsequent changes in blood pressure. The study uses a quasi-experimental regression discontinuity design with existing population-based secondary data from the 2008, 2010, 2012, 2014, and 2017 waves of the National Income Dynamics Study in South Africa.

NCT ID: NCT03760562 Completed - Hypertension Clinical Trials

The Risk of Hypertension Associated With Oral Glucocorticoids in Chronic Inflammatory Diseases

Start date: January 1, 1998
Study type: Observational

Glucocorticoids are widely used for the treatment of chronic inflammatory diseases. In 2008, it was estimated that 0.8% of the United Kingdom adult population had used long-term (≥ 3 months) glucocorticoids, rising to 3% in women aged over 80 years. The aim of the project is to investigate the dose-response estimates of risk of high blood pressure associated with oral glucocorticoids.

NCT ID: NCT03747978 Completed - Hypertension Clinical Trials

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

Start date: October 1, 2016
Phase: Phase 4
Study type: Interventional

This was a double-blinded randomized controlled trial of 24-hour blood pressure control in sub Saharan type 2 diabetes patients, newly diagnosed for hypertension. They were allocated to receive either a fixed combination of perindopril + amlodipine or perindopril + indapamide for 42 days.

NCT ID: NCT03716960 Completed - Hypertension Clinical Trials

The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Postmenopausal women have a higher prevalence of cardiovascular (CV) disease than age-match men. Growing evidence from rat studies have demonstrated CV-protective effects of pumpkin seed oil (PSO). The investigators hypothesis is that PSO would improve CV health in postmenopausal women.